磷酸化核转录因子NFKB-RelB蛋白抗体

英文名称    Phospho-RelB(Ser573)    

中文名称    磷酸化核转录因子NFKB-RelB蛋白抗体    

别    名    RelB(Phospho-Ser573); RELB(phospho S573); I REL; IREL; Nuclear factor of kappa light polypeptide gene enhancer in B cells 3; RelB; Reticuloendotheliosis viral oncogene homolog B; Transcription factor RelB; v rel avian reticuloendotheliosis viral oncogene homolog; v rel reticuloendotheliosis viral oncogene homolog B; RELB_HUMAN; I-Rel.    

磷酸化核转录因子NFKB-RelB蛋白抗体        

说 明 书    0.1ml      

产品类型    磷酸化抗体     

研究领域    肿瘤  细胞生物  免疫学  信号转导  细胞凋亡  转录调节因子      

抗体来源    Rabbit    

克隆类型    Polyclonal    

交叉反应    Human, Mouse, Rat, Dog, Cow, Horse, Rabbit, Sheep, Guinea Pig,     

产品应用    WB=1:100-500 ELISA=1:500-1000 IP=1:20-100 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500 （石蜡切片需做抗原修复） 
not yet tested in other applications.
optimal dilutions/concentrations should be determined by the end user.    

分 子 量    64kDa    

细胞定位    细胞核 细胞浆     

性    状    Lyophilized or Liquid    

浓    度    1mg/1ml    

免 疫 原    KLH conjugated Synthesised phosphopeptide derived from human RelB around the phosphorylation site of Ser573    

亚    型    IgG    

纯化方法    affinity purified by Protein A    

储 存 液    0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodium azide    

保存条件    Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.    

磷酸化核转录因子NFKB-RelB蛋白抗体产品介绍    background:
The NFKB complex consists of NFKB1 or NFKB2 bound to REL, RELA, or RELB. The NFKB complex is inhibited by I kappa B proteins (NFKBIA, or NFKBIB), which inactivate NF kappa B by trapping it in the cytoplasm. Phosphorylation of serine residues on the I kappa B proteins by kinases (IKBKA, or IKBKB,) marks them for destruction via the ubiquitination pathway, thereby allowing activation of the NF kappa B complex. For some genes, activation requires NFKB interaction with other transcription factors, such as STAT, AP1 (JUN), and NFAT.

Function:
NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators. RELB neither associates with DNA nor with RELA/p65 or REL. Stimulates promoter activity in the presence of NFKB2/p49. As a member of the NUPR1/RELB/IER3 survival pathway, may provide pancreatic ductal adenocarcinoma with remarkable resistance to cell stress, such as starvation or gemcitabine treatment.

Subunit:
Component of the NF-kappa-B RelB-p50 complex. Component of the NF-kappa-B RelB-p52 complex. Self-associates; the interaction seems to be transient and may prevent degradation allowing for heterodimer formation with p50 or p52. Interacts with NFKB1/p50, NFKB2/p52 and NFKB2/p100. Interacts with NFKBID.

Subcellular Location:
Nucleus. Cytoplasm, cytoskeleton, centrosome. Note=Co-localizes with NEK6 in the centrosome.

Post-translational modifications:
Phosphorylation at 'Thr-103' and 'Ser-573' is followed by proteasomal degradation.

Similarity:
Contains 1 RHD (Rel-like) domain.

Database links:
UniProtKB/Swiss-Prot: Q01201.2

Important Note:
This product as supplied is intended for research use only, not for use in human, therapeutic or diagnostic applications.    

磷酸化核转录因子NFKB-RelB蛋白抗体

hz-3112R Phospho-EGFR (Tyr998)  磷酸化表皮生长因子受体抗体

hz-4077R Phospho-EGFR (Tyr992)   磷酸化表皮生长因子受体抗体

hz-4078R Phospho-EGFR (Tyr1101)  磷酸化表皮生长因子受体抗体

hz-2008R EGF(human)  表皮生长因子抗体（人）

hz-1644R phospho-EGFR (Tyr1068)  磷酸化表皮生长因子受体抗体

hz-5307R phospho-EGFR (Ser1026)  磷酸化表皮生长因子受体抗体

hz-5308R phospho-EGFR (Ser1166)  磷酸化表皮生长因子受体抗体

hz-5309R phospho-EGFR (Ser1190)  磷酸化表皮生长因子受体抗体

hz-5310R phospho-EGFR (Ser695)  磷酸化表皮生长因子受体抗体

hz-5311R phospho-EGFR (Ser1070)  磷酸化表皮生长因子受体抗体

hz-5312R phospho-EGFR (Tyr1125)  磷酸化表皮生长因子受体抗体

hz-5313R phospho-EGFR (Tyr869)  磷酸化表皮生长因子受体抗体

hz-5314R phospho-EGFR (Thr693)  磷酸化表皮生长因子受体抗体

hz-5315R phospho-EGFR (Tyr1092)  磷酸化表皮生长因子受体抗体

hz-5316R phospho-EGFR (Tyr1110)  磷酸化表皮生长因子受体抗体

hz-2009R EGF(mouse)  表皮生长因子抗体（小鼠）

hz-1454R ErbB-3/HER3  表皮生长因子受体3抗体

hz-5317R phospho-EGFR (Tyr1197)  磷酸化表皮生长因子受体抗体

hz-5318R phospho-EGFR (Tyr1172)  磷酸化表皮生长因子受体抗体

hz-5319R phospho-EGFR (Thr678)  磷酸化表皮生长因子受体抗体

hz-5320R phospho-EGFR (Ser768)  磷酸化表皮生长因子受体抗体

hz-5321R phospho-EGFR (Tyr1016)  磷酸化表皮生长因子受体抗体

hz-5322R phospho-EGFR (Ser1142)  磷酸化表皮生长因子受体抗体

hz-5333R phospho-EGFR (Ser967)  磷酸化表皮生长因子受体抗体

hz-2010R EGF  表皮生长因子抗体（大鼠）

hz-1755R EGFL7  类表皮生长因子域7抗体

hz-5877R MUC13  粘蛋白13抗体

hz-0405R EGFR  表皮生长因子受体抗体

hz-5878R MUC15  粘蛋白15抗体

hz-2503R EF1a  翻译延伸因子EF-1a抗体

hz-2558R EGFRvIII  表皮生长因子受体III型突变体抗体

hz-1076R Egr1  早期生长应答蛋白1抗体

hz-5879R MUC7  粘蛋白7抗体

hz-5880R CDCP1/CD318  CD318抗体

hz-4103R EIF4B  真核翻译起始因子4B抗体

hz-5345R phospho-EIF4B (Ser422)  磷酸化真核翻译起始因子4B抗体

hz-5346R phospho-EIF4B (Ser540)  磷酸化真核翻译起始因子4B抗体